LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 50 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,019,000 | -3.2% | 1,385,309 | -7.6% | 0.31% | -1.0% |
| Q4 2016 | $10,349,000 | -27.8% | 1,498,809 | -14.4% | 0.31% | -41.9% |
| Q3 2016 | $14,335,000 | +10.7% | 1,751,509 | +9.6% | 0.54% | -39.4% |
| Q2 2016 | $12,946,000 | +59.5% | 1,598,309 | 0.0% | 0.89% | +78.9% |
| Q1 2016 | $8,119,000 | -26.6% | 1,598,309 | +11.5% | 0.50% | -19.8% |
| Q4 2015 | $11,068,000 | +34.0% | 1,433,700 | 0.0% | 0.62% | +119.4% |
| Q3 2015 | $8,258,000 | -37.2% | 1,433,700 | 0.0% | 0.28% | +42.2% |
| Q2 2015 | $13,147,000 | -18.1% | 1,433,700 | +8.2% | 0.20% | -77.7% |
| Q1 2015 | $16,046,000 | – | 1,325,000 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
| Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
| FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
| Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
| Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
| Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
| Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
| QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
| Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |